A lawsuit filed Monday accused three makers of insulin — Sanofi, Novo Nordisk and Eli Lilly — of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills.
A lawsuit filed Monday accused three makers of insulin — Sanofi, Novo Nordisk and Eli Lilly — of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills. File photo by James Estrin The New York Times
A lawsuit filed Monday accused three makers of insulin — Sanofi, Novo Nordisk and Eli Lilly — of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills. File photo by James Estrin The New York Times